{"paperId": "9a7e3147274f514e22dff4cf8bf6e82cf44acca2", "publicationVenue": {"id": "eacf3df5-edb0-41b1-b1f2-b3369bd272c2", "name": "Digestive Diseases and Sciences", "type": "journal", "alternate_names": ["Dig Dis Sci"], "issn": "0163-2116", "url": "http://www.kluweronline.com/issn/0163-2116/contents", "alternate_urls": ["http://link.springer.com/journal/12364", "https://link.springer.com/journal/10620", "https://www.springer.com/medicine/internal/journal/10620", "http://www.springer.com/medicine/internal/journal/10620"]}, "title": "Comparative Long-Term Drug Survival of Vedolizumab, Adalimumab, and Infliximab in Biologic-Na\u00efve Patients with Ulcerative Colitis", "abstract": null, "venue": "Digestive Diseases and Sciences", "year": 2022, "fieldsOfStudy": ["Medicine"], "publicationTypes": ["JournalArticle"], "publicationDate": "2022-04-12", "journal": {"name": "Digestive Diseases and Sciences", "pages": "223-232", "volume": "68"}, "authors": [{"authorId": "4979601", "name": "R. Dalal"}, {"authorId": "119057696", "name": "E. McClure"}, {"authorId": "23227999", "name": "J. Marcus"}, {"authorId": "6553325", "name": "J. Allegretti"}], "citations": [{"paperId": "cf9fc64186404ecdee8be85abcd4e997ef44e104", "title": "Durability of the First Biologic in Children and Adults With Ulcerative Colitis: A Nationwide Study from the epi-IIRN."}, {"paperId": "c391a254ae93d4f24af59e41a4b36e7a5b4861b8", "title": "A Retrospective Observational Study of Patterns of Biologic Drug Change in Inflammatory Bowel Disease"}, {"paperId": "6fad0c82f910fc36b43f621ad60194bebff259b0", "title": "Network meta-analysis on efficacy and safety of different biologics for ulcerative colitis"}, {"paperId": "0325b7d1d0d5b424ffcb1b9b25c1920a6e4f0369", "title": "1-Year Comparative Effectiveness of Tofacitinib vs Ustekinumab for Patients With Ulcerative Colitis and Prior Antitumor Necrosis Factor Failure."}, {"paperId": "e4f38fbd4540db9371f1dba6cd077fedda4b4823", "title": "Effects of immunosuppressive treatment on patient outcomes after immune checkpoint inhibitor-related gastrointestinal toxicity"}]}
